
Reset all filters
01 18Crestor
02 2Crestor
03 3Rosuzet
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 206
2018 Revenue in Millions : 205
Growth (%) : 0
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 82
2018 Revenue in Millions : 100
Growth (%) : -19
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 1,180
2019 Revenue in Millions : 1,278
Growth (%) : -8
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 210
2019 Revenue in Millions : 210
Growth (%) : 0
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 1,096
2020 Revenue in Millions : 1,180
Growth (%) : -7
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 68
2019 Revenue in Millions : 84
Growth (%) : -18
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 10
2020 Revenue in Millions : 201
Growth (%) : -95
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 52
2020 Revenue in Millions : 66
Growth (%) : -14
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 68
2020 Revenue in Millions : 130
Growth (%) : -48
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 1,048
2021 Revenue in Millions : 1,096
Growth (%) : -4